The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
D015250:Aclarubicin / Q000031:analogs & derivatives*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000494:pharmacology*; D005290:Ferric Compounds / Q000494:pharmacology; D006162:Guanylate Cyclase / Q000378:metabolism*; D008099:Liver / Q000201:enzymology; D008297:Male; D017290:Menogaril; D009206:Myocardium / Q000201:enzymology; D009279:Naphthacenes / Q000494:pharmacology*; D009621:Nogalamycin / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014018:Tissue Distribution
D000903:Antibiotics, Antineoplastic; D005290:Ferric Compounds; D009279:Naphthacenes; C011157:aclacinomycins; C018376:quelamycin; D015250:Aclarubicin; D004317:Doxorubicin; D017290:Menogaril; D006162:Guanylate Cyclase; D009621:Nogalamycin